flecha

News

flecha
686 SPANISH BIOTECHNOLOGY INVENTIONS IDENTIFIED IN 2010 16/5/2011
25% of new biotechnology companies created in Spain in 2010 are Andalusian.
A total of 686 Spanish biotechnological inventions were identified during 2010, according to the report by the Spanish Association of Biotechnology Enterprises (Asebio), which highlights the "huge increase" experienced by the sector in this regard with the previous year, since, according to the director general of the Science Park of Madrid, Antonio Diaz in 2009, there were 430 inventions.

Similarly, Diaz pointed out that a total of 324 biotechnology patents registered last year by companies associated with Asebio. In this regard, he pointed out that the most active institution in the field of intellectual property is the CSIC with 156 inventions, followed by the Proyecto de Biomedicina CIMA (20), Laboratorios Esteve (13), PharmaMar (9) and Grifols Engineering (5).

In terms of scientific publications of Spanish companies in various magazines or specialized media have been computed a total of 133 impacts, which shall belong to a dozen entities.

The report notes that this activity is due to many years growth is occurring in the biotechnology sector and has led him to exceed 50,000 million in revenues in 2009, 70% more than in 2008. In this sense, Asebio underlined the crosscutting nature of biotechnology makes companies increasingly incorporate biotechnology activities in their products and services.

Specifically, the report notes that the number of companies engaged in activities related to the sector amounted to 1,095 in 2009, with a growth rate of 16.2%. Of these, 399 have developed biotechnology as core business and / or proprietary, which means a 30 percent increase over the previous year.


57 new biotech companies:

As for the figures of 2010, anticipates that were created Asebio 57 new biotech companies, this figure was "noteworthy," as explained by the Scientific Committee member of the association, Emilio Muñoz. In this regard, he highlighted that Andalusia (with 25%) and Catalonia (with 23%) are more companies created autonomy.

Muñoz has also pointed out that last year there were 143 partnerships, of which 45% were made between biotech companies and public entities, 33 percent with other biotech companies, and 22 percent with business users.

In presenting the report, the Minister for Science and Innovation, Cristina Garmendia has reiterated the commitment of his department to "continue deploying the necessary steps to make the sector continues to grow and generate employment so that it can contribute significantly to economic recovery ".

In addition, Garmendia has been estimated that, throughout 2011, will be allocated 280 million euros through various programs relating to the health sector, "with special emphasis on the field of R + D + i biopharmaceutical.

For its part, Asebio president, José María Fernández Sousa-Faro, explained that the partnership will "continue fighting for the growth of the sector in Spain."

Source: Europa Press
 
 
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Search
linea
Google Custom Search
BioRegión Collaborative Area
BioRegión Collaborative Area
RSS
linea
RSS RSS Andalucía BioRegión
User Acces
linea
Email:
Password:

Register

Forgot your password?

Companies/centers Acces
line
Email:
Password:

Register your company

Forgot your password?

Tag cloud
line
View more tags
BioRegión Collaborative Area